151 related articles for article (PubMed ID: 7079160)
21. Prevention of recurrent nephrolithiasis.
Goldfarb DS; Coe FL
Am Fam Physician; 1999 Nov; 60(8):2269-76. PubMed ID: 10593318
[TBL] [Abstract][Full Text] [Related]
22. [Bicarbonate calcium mineral water with carbon dioxide in rehabilitation of children with dismetabolic nephropathies complicated by renal inflammation].
Ni AN; Popova VV; Luchaninova VN
Vopr Kurortol Fizioter Lech Fiz Kult; 2004; (4):32-5. PubMed ID: 15449672
[TBL] [Abstract][Full Text] [Related]
23. [Physicochemical basis for the formation of calcium oxalate renal stones. Estimation of the degree of urine saturation with the activity product ratio (CPA) (author's transl)].
Peña JC; Fishleder S; Galván P; Herrera-Acosta J
Rev Invest Clin; 1981; 33(4):333-41. PubMed ID: 7330508
[No Abstract] [Full Text] [Related]
24. [Use of "Serebrianyĭ Kliuch" mineral water in the postoperative treatment of patients with nephrolithiasis after extracorporeal shock-wave lithotripsy].
Neĭmark AI; Davydov AV
Urologiia; 2003; (4):44-6. PubMed ID: 12942727
[TBL] [Abstract][Full Text] [Related]
25. [Combined use of drinking mineral water and the natural enterosorbent zosterine in kidney stones (an experimental study)].
Gvozdenko TA; Antoniuk MV; Ivanova IL; Ian'kova VI
Vopr Kurortol Fizioter Lech Fiz Kult; 2001; (5):30-3. PubMed ID: 11785335
[TBL] [Abstract][Full Text] [Related]
26. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
27. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
Berland Y
Nephrologie; 1999; 20(7):363-9. PubMed ID: 10642984
[TBL] [Abstract][Full Text] [Related]
28. [An observational and longitudinal study on patients with kidney stones treated with Fiuggi mineral water].
Serio A; Fraioli A
Clin Ter; 1999; 150(3):215-9. PubMed ID: 10528434
[TBL] [Abstract][Full Text] [Related]
29. [Expulsion treatment of urinary calculi by the association of diuresis and mechanical actions].
Cottet J; Auvert J
J Urol Nephrol (Paris); 1969 Sep; 75(9):672-7. PubMed ID: 5406091
[No Abstract] [Full Text] [Related]
30. [Effects of sucrose ingestion on calciuria and other urinary constituents in renal lithiasis patients and in asymptomatic relatives].
González-Calvin JL; Zuluaga Gómez A; García-Valdecasas J; Núñez Carril J; Mora Lara J; Peña Angulo JF; Peña Yáñez A
Rev Clin Esp; 1982 Jun 15-30; 165(5-6):325-7. PubMed ID: 7134554
[No Abstract] [Full Text] [Related]
31. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
Pak CY
Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289
[TBL] [Abstract][Full Text] [Related]
32. [Role of phosphate in recurrent calcium lithiasis. A current view].
Reina Ruiz MC; Conde Sánchez JM; Domínguez Domínguez M; Espinosa Olmedo J; García Pérez M
Arch Esp Urol; 2001 Nov; 54(9):1029-35. PubMed ID: 11789360
[TBL] [Abstract][Full Text] [Related]
33. [An efficacy study of the treatment of patients with chronic pyelonephritis and urolithiasis using sulfate-bicarbonate calcium-magnesium mineral water].
Telina EN; Sakhabutdinov IuE; Mosikhina SS; Anisimova IV; Nizamova FA
Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (4):26-8. PubMed ID: 10513468
[TBL] [Abstract][Full Text] [Related]
34. [Conservative treatment of nephrolithiasis].
Lurie A
Harefuah; 1972 Jul; 83(2):78-80. PubMed ID: 5068914
[No Abstract] [Full Text] [Related]
35. Pathophysiology and management of calcium stones.
Park S; Pearle MS
Urol Clin North Am; 2007 Aug; 34(3):323-34. PubMed ID: 17678983
[TBL] [Abstract][Full Text] [Related]
36. [3 years' experience in the prevention of recurrent calcic nephrolithiasis].
Tessitore N; D'Angelo A; Pagano F; Loschiavo C; Fabris A; Lupo A; Tasca A; Morachiello P; Valvo E; Previato G; Chiaramonte S; Sidoti O; Maschio G
Minerva Nefrol; 1980; 27(2):267-70. PubMed ID: 7219849
[No Abstract] [Full Text] [Related]
37. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
[TBL] [Abstract][Full Text] [Related]
38. [Drinking mineral water in combined therapy of nephrolithiasis].
Neĭmark AI; Davydov AV; Bunkov VV; Zhiliakova LV; Ukrainskaia LM
Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (3):32-4. PubMed ID: 16060281
[No Abstract] [Full Text] [Related]
39. [The use of mercapto-propionyl-glycine in the treatment of cystine lithiasis (author's transl)].
Dimopoulos C; Stokidis D; Kallistratos G; Sidéris C; Kyriakidis A; Kollias G
J Urol (Paris); 1981; 87(5):265-8. PubMed ID: 7276604
[TBL] [Abstract][Full Text] [Related]
40. [Randomized trials in the prevention of recurrent calcium oxalate stones].
Presne C; Monge M; Bataille P; el Esper N; Choukroun G; Fournier A
Nephrologie; 2003; 24(6):303-7. PubMed ID: 14584297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
